| Date | Form | Description | Docs | XBRL | Pages |
| 10/16/17 | S-3 | Registration statement for specified transactions by certain issuers |
|
30 | |
| 10/03/17 | 8-K | Current report filing |
|
4 | |
| 10/02/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/02/17 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 09/29/17 | 8-K | Current report filing |
|
34 | |
| 09/29/17 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
52 | |
| 09/27/17 | 8-K | Current report filing |
|
3 | |
| 09/26/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/26/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/26/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
Read More...Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
Read More...Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
Read More...